Is Thermo Fisher Scientific Inc. (TMO) a leader in the diagnostics and research industry?

Thermo Fisher Scientific Inc. (TMO) is at the top of the diagnostics and research industry according to InvestorsObserver. TMO received an overall rating of 63, meaning it scores above 63% of all actions. Thermo Fisher Scientific Inc. also scored 95 in the diagnostics and research industry, putting it above 95% of diagnostics and research stocks. Diagnostics & Research is ranked 125 out of 148 industries.

TMO has an overall score of 63. Find out what this means for you and get the rest of the rankings on TMO!

What do these notes mean?

Finding the best stocks can be tricky. It is not easy to compare companies from one sector to another. Even companies that have relatively similar activities can sometimes be difficult to compare. InvestorsObserverThe tools allow for a top-down approach that lets you pick a metric, find the best sector and industry, and then find the best stocks in that sector. These rankings allow you to easily compare stocks and see what the strengths and weaknesses of a given company are. This lets you find the stocks with the best short and long-term growth prospects in seconds. The combined score incorporates technical and fundamental analysis to provide a comprehensive view of a stock’s performance. Investors who then want to focus on analyst rankings or valuations can view separate scores for each section.

What’s going on with Thermo Fisher Scientific Inc. stock today?

Thermo Fisher Scientific Inc. (TMO) stock is -1.36% lower while the S&P 500 is 0.13% higher at 2:56 p.m. Wednesday, February 16. TMO is -$7.57 lower than the previous closing price of $556.16 on the volume of 1,338,184 shares. Over the past year, the S&P 500 has gained 13.84% while the TMO is 9.70% higher. TMO has earned $19.46 per share over the past 12 months, giving it a price-to-earnings ratio of 28.26. Click here for the full inventory report from Thermo Fisher Scientific Inc.

Stay in the know

Subscribe to our daily morning update newsletter and never miss market news, moves and more.

Thank you for signing up! You are ready to receive the Morning Update newsletter

Comments are closed.